Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04473690 · ClinicalTrials.gov registry record · Phase 1
KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers
A Phase 1 study of COVID-19, sponsored by KBio.
- Completed
- Registry status
- Phase 1
- Development phase
- 102
- Enrollment target
- 8
- Study locations
NCT04473690: Completed Phase 1 study of COVID-19, sponsored by KBio.
NCT04473690 is a Phase 1 study of COVID-19 that has completed, run by KBio. The registered enrollment target is 102 participants, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04473690, a Phase 1 study of COVID-19, has completed, sponsored by KBio.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 102 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is an First In Human (FIH), observer-blinded, randomized, placebo-controlled, parallel group study to evaluate the safety and immunogenicity of KBP-COVID-19 plus CPG adjuvant vaccine in healthy adult subjects in 2 age groups, Part A (18-49 years) and Part B (50-85 years).
Primary Outcome
Occurrence of Adverse Events
Conditions Studied
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Low Dose of KBP-COVID-19
- BIOLOGICAL High Dose of KBP-COVID-19
Study Locations (8)
Texas
- PanAmerican Clinical Research - Brownsville
- ICON - San Antonio
- DM Clinical Research - Tomball
Florida
- Palm Beach Research Center - West Palm Beach
Idaho
- Velocity Clinical Research - Meridian
North Carolina
- PMG Research of Winston-Salem - Winston-Salem
Burlington/Ontario
- LMC Manna Research - Burlington
Point Claire, Quebec
- LMC Manna Research - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2020-12-30 |
| Est. Completion | 2022-10-14 |
| Phase | Phase 1 |
What the finished NCT04473690 record still lists
NCT04473690 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT04473690 lists 8 locations in 6 states (Texas, Florida, Idaho).
Frequently Asked Questions
What is clinical trial NCT04473690 about?
NCT04473690 is a clinical study titled "KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers". This is an First In Human (FIH), observer-blinded, randomized, placebo-controlled, parallel group study to evaluate the safety and immunogenicity of KBP-COVID-19 plus CPG adjuvant vaccine in healthy adult subjects in 2 age groups, Part A (18-49 years) and Part B (50-85 years).
What is the current status of trial NCT04473690?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 102 participants. The study started on 2020-12-30. Estimated completion is 2022-10-14.
What conditions does trial NCT04473690 study?
This clinical trial studies the following conditions: COVID-19.
What interventions are being tested in trial NCT04473690?
The interventions under investigation include: Placebo (BIOLOGICAL), Low Dose of KBP-COVID-19 (BIOLOGICAL), High Dose of KBP-COVID-19 (BIOLOGICAL).
Who is sponsoring clinical trial NCT04473690?
This trial is sponsored by KBio, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04473690 being conducted?
This trial has 8 study locations across Florida, Idaho, North Carolina, Texas, Burlington/Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04473690's enrollment target sits among peer trials
102 199th of 298 higher than 100 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Positron Emission Tomography (PET) Imaging of Thrombosis
RECRUITING · Phase 1
-
A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
RECRUITING · Phase 1
-
A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
RECRUITING · Phase 1
-
A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
RECRUITING · Phase 1
-
A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers
ACTIVE NOT RECRUITING · Phase 1
-
Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET)
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI